Joseph Douglas Lyon, Chief Accounting Officer: Corcept Therapeutics CORT Sell · Filed 24/02/21

Trade details

Type: Insider sale
Amount: $26,000
Shares · price: 1,000 sh · $26.00 a share
Held after: 6,774 sh
Stock: Corcept Therapeutics CORT
Person: Joseph Douglas LyonChief Accounting Officer
Trade date: 24/02/16
Filed: 24/02/21
Days to filing: 5 days

Sold 12.9% of holdings

Share of holding sold: 12.9%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/17~24/03/17

Joseph Douglas Lyon's recent trades

Joseph Douglas LyonSEE REMARKS
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.2M
10,000 sh
$1.2M
Filed 10/01
Traded 10/01
Joseph Douglas LyonSEE REMARKS
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.1M
10,000 sh
$1.1M
Filed 09/14
Traded 09/14
Joseph Douglas LyonSEE REMARKS
Planned saleCorcept Therapeutics
Planned sale
Corcept Therapeutics
CORT
$175.8K
1,540 sh
$175.8K
Filed 08/03
Traded 08/03
Joseph Douglas LyonSEE REMARKS
SellCorcept Therapeutics
Sell
Corcept Therapeutics
CORT
$325K
5,000 sh
$325K
Filed 05/29
Traded 05/27
Joseph Douglas LyonSEE REMARKS
Planned saleCorcept Therapeutics
Planned sale
Corcept Therapeutics
CORT
$291.1K
5,000 sh
$291.1K
Filed 05/20
Traded 05/20

Joseph Douglas Lyon, CAO — sold $26K of Corcept Therapeutics CORT · 12.9% of holdings · 10b5-1 plan | Whalegun